Chronic immune sensory polyradiculopathy associated with monoclonal gammopathy of undetermined significance

Czech version

Authors: P. Potužník; J. Vejskal
Authors‘ workplace: Neurologická klinika LF UK a FN Plzeň
Published in: Cesk Slov Neurol N 2022; 85(6): 509-510
Category: Letter to Editor
doi: https://doi.org/10.48095/cccsnn2022509

Sources

1. Shelly S, Shouman K, Paul P et al. Expanding the spectrum of chronic immune sensory polyradiculopathy: CISP-Plus. Neurology 2021; 96 (16): e2078–e2089. doi: 10.1212/WNL.0000000000011792.

2. Van den Bergh PYK, van Doorn PA, Hadden RDM et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. J Peripher Nerv Syst 2021; 26 (3): 242–268. doi: 10.1111/jns.12455.

3. Menon D, Katzberg HD, Bril V. Treatment approaches for atypical CIDP. Front Neurol 2021; 12: 653734. doi: 10.3389/fneur.2021.653734.

4. Sinnreich M, Klein CJ, Daube JR et al. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology 2004; 63 (9): 1662–1669. doi: 10.1212/01.wnl.0000142507.12763.58.

5. Cocito D, Durelli L, Isoardo G. Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia. Acta Neurol Scand 2003; 108 (4): 274–280. doi: 10.1034/j.1600-0404.2003.00 127.x.